JQ1 Downregulates IL-20RA Expression in Triple Negative Breast Cancer Cells In Vitro and In Vivo. [PDF]
Maggisano V +5 more
europepmc +1 more source
BRD2 upregulation as a pan-cancer adaptive resistance mechanism to BET inhibition. [PDF]
Archasappawat S +3 more
europepmc +1 more source
Direct toll-like receptor 4 inhibition in Alzheimer's disease models: a focused scoping review of inflammatory, amyloid-handling, and functional outcomes. [PDF]
Ren X, Jin X, Li L, Li F.
europepmc +1 more source
scTumorDrug: predicting cell-type-specific drug responses for heterogeneous tumors. [PDF]
Zhang Q, Zhang Q, Guo C, Peng C.
europepmc +1 more source
Resistance to the KRASG12D Inhibitor MRTX1133 Is Associated with Increased Sensitivity to BET Inhibition. [PDF]
Principe DR +6 more
europepmc +1 more source
Targeting BRD2 and BRD4 inhibit the growth of KSHV-infected immortalized endothelial cells through suppression of LANA translation. [PDF]
Chen J +6 more
europepmc +1 more source
Unc-51 like kinase 3 (ULK3) contributes to autophagy and cell survival in multiple myeloma. [PDF]
Tauro M +25 more
europepmc +1 more source
Single-Cell Computational Frameworks for Quantifying BET Bromodomain Inhibitor Resistance and Screening Re-Sensitizer Drugs in Triple-Negative Breast Cancer. [PDF]
Liu H +6 more
europepmc +1 more source
Cell painting and thermal proteome profiling for inference of drug targets and mechanism of action. [PDF]
Johansson C +8 more
europepmc +1 more source
Enzyme-Induced Supramolecular Proteolysis-Targeting Chimeras Enable Tumor-Targeted Protein Degradation. [PDF]
Liang C +8 more
europepmc +1 more source

